Cal-Maine Foods, Inc. research snapshot
CALM AI stock analysis currently reads Cal-Maine Foods as the largest US shell egg producer with a high dividend yield near 5.4%, strong recent earnings from avian flu-related egg price spikes, but also elevated regulatory, commodity-price, and concentrated-family-control risks. At the July 12, 2026 data cutoff, CALM traded near $88.34 with a verified market capitalization near $4.19 billion. This page uses scenario ranges and source checks, not a certain stock price prediction, and is for informational use only.
Current price
$88.34
Market cap
$4.19 billion
AI score
53 / 100
Rating
Commodity egg producer with dividend, avian flu tailwind, and DOJ overhang
Trend status
Recovered above all major moving averages, RSI overbought near 74
Data cutoff (updated weekly)
July 12, 2026
Informational use only. This page is not investment advice.
| Dimension | Conclusion | Confidence |
|---|---|---|
| Business quality | Cal-Maine is the largest US shell egg producer at roughly 20% market share, selling a perishable commodity through retail, food service, and egg product channels. The business generates strong cash flow when egg prices are high but faces sharp reversals when supply normalizes. | Medium |
| Moat | Moat comes from scale in production, distribution, logistics, and customer relationships with major grocery chains and food service operators. But eggs are a commodity with limited pricing power, and competitors can expand supply quickly when margins are attractive. | Low-medium |
| Management | Management has navigated avian flu disruptions, completed the Tyson Foods Dexter facility acquisition, and maintained a high dividend payout. However, the Adams family holds controlling interest, creating governance concentration risk and potential minority shareholder concerns. | Medium |
| Financial trend | Trailing twelve-month revenue through February 2026 was approximately $3.46 billion and net income approximately $695 million. Earnings are highly cyclical with egg prices; the May 2025 quarter showed $1.10B revenue and $342M net income, while the February 2026 quarter slowed to $667M revenue and $50M net income. | High |
| Valuation | At $88.34, CALM trades at 6.2x trailing EPS of $14.35, with a 5.4% dividend yield. The three-scenario framework produces a bearish area near $49, a base area near $100, and a bullish area near $153 over three years, depending on egg price trajectory and normalized earnings. | Medium |
| Technical trend | Price is above all major moving averages (8, 20, 50, 200-day SMA and EMA) after a strong rally from the 52-week low near $72. RSI at 73.54 is overbought, suggesting some caution. MACD is bullish at 2.35. | Medium |
| Risk level | Main risks include egg price mean-reversion, avian flu outbreak uncertainty, DOJ antitrust investigation, family controlling interest, commodity input cost volatility (feed), customer concentration, and historical price-fixing litigation. | Medium-high |
| AI confidence | High for descriptive facts and audited calculations, medium for forward scenarios and chart levels. | High data confidence |
| Investment certainty | Low to medium certainty. The page frames scenarios and monitoring rules, not a buy or sell instruction. | Low-medium |
CALM AI stock forecast
The CALM AI stock forecast uses scenario math around the $88.34 quote and trailing EPS of $14.35. The audited three-year framework produced a bearish area near $49, a base area near $100, and a bullish area near $153. Actual outcomes depend heavily on egg prices, avian flu developments, and the DOJ investigation.
$145 to $160
More likely if avian flu continues to constrain supply, egg prices remain elevated, Cal-Maine sustains strong margins, the DOJ investigation resolves without material penalty, and the market assigns a higher multiple near 8x normalized earnings.
$95 to $105
More likely if egg prices moderate from peak levels, Cal-Maine maintains above-average but not exceptional margins, the dividend remains sustainable, and the stock trades near 6x normalized EPS of roughly $16 to $17.
$45 to $55
More likely if egg prices collapse as supply normalizes, avian flu subsidies and indemnity payments decrease, the DOJ investigation leads to fines or operational restrictions, or the dividend is cut as earnings normalize.
CALM AI technical analysis
CALM AI technical analysis shows a strong uptrend as of the July 12, 2026 data cutoff, with price well above all major moving averages. The stock rallied from a 52-week low of $71.92 to $88.34. However, the RSI at 73.54 is in overbought territory, suggesting the near-term move may be extended and a pullback or consolidation could develop.
| Level | Value | Why it matters |
|---|---|---|
| Current price | $88.34 | Quote snapshots around the July 10, 2026 cutoff placed CALM near $88.34. |
| Near support | $84.28 to $80.96 | Financhill listed the 8-day SMA near $84.28 and the 20-day SMA near $80.96, making this the first pullback zone to monitor. |
| Deeper support | $78 to $76 | The 50-day SMA near $78.32 and the lower Bollinger Band (25) near $76.65 represent stronger support levels. |
| Near resistance | $90 to $100 | Psychological resistance near $90, followed by the analyst target zone around $100 (Benchmark buy target). |
| Long-term resistance | $126.40 | The 52-week high of $126.40 remains the upper reference point if the rally extends further. |
| Momentum | RSI roughly 73.54 | Financhill listed RSI near 73.54, which is in overbought territory and suggests caution on chasing the move. |
| Volume | Average volume near 796,000 shares | Google Finance listed average volume near 795,670 shares, useful for judging breakout quality. |
| Volatility | About 30% below the 52-week high | Recent Google Finance snapshots described CALM as still about 30% below its $126.40 52-week high despite the recent rally. |
| Invalidation | Close below $78 | A decisive close below the 50-day SMA near $78 would weaken the near-term uptrend and suggest a deeper correction. |
CALM AI trading strategy
The CALM AI trading strategy is a rules-based research framework for monitoring a commodity egg producer with high earnings cyclicality and family control. It is not personal advice and should be paired with fresh egg price data, avian flu reports, DOJ investigation updates, position sizing, and a defined invalidation level.
Watch for CALM to hold above the $80 to $84 moving average zone, then clear $90 on volume above average. A sustained move toward $100 to $110 would require continued strength in egg prices and no adverse DOJ news.
A close below $78 or a negative DOJ announcement should invalidate the near-term trend setup.
If CALM pulls back toward the $76 to $80 area on egg price normalization fears but dividend coverage remains strong, compare the 5.4% dividend yield with safety metrics and management commentary before assuming support is durable.
Do not buy the dip without a maximum loss rule because commodity egg stocks can gap down on avian flu, regulatory, or earnings-revision news.
Track egg prices (USDA survey), quarterly revenue and margin trends, avian flu outbreak map, DOJ investigation milestones, dividend declaration and coverage ratio, feed cost indicators (corn, soybean), and insider selling patterns.
Reduce confidence if the DOJ investigation escalates, the dividend is cut, or quarterly earnings show a sustained downward trend in egg prices and margins.
Investment research summary
Cal-Maine produces, processes, and distributes shell eggs to grocery retailers, food service operators, and egg product manufacturers. Customers pay because eggs are a staple protein, and Cal-Maines scale, distribution network, and customer relationships make it the default large-volume supplier.
The moat is scale-based rather than durable. Cal-Maines 20% US market share, national distribution, and long-standing grocery relationships create barriers for small producers, but large customers can switch suppliers when price is the main variable, and industry capacity can expand when margins attract.
The thesis fails if egg prices mean-revert as avian flu disruptions ease, the DOJ antitrust investigation produces fines or structural remedies, the family controlling interest leads to poor capital allocation, or the dividend is cut as earnings normalize.
Management should be judged by capital allocation through the cycle (capex, acquisitions, dividend policy), transparency with minority shareholders given family control, balance sheet discipline, and how they navigate the DOJ investigation and regulatory environment.
Egg consumption remains relatively stable as a staple protein, but the industry faces trends toward cage-free production, avian flu as a recurring disruptor, potential regulatory changes, and consumer preference shifts. Cal-Maine benefits from industry consolidation trends.
At roughly 6.2x trailing EPS with a 5.4% dividend yield, CALM appears cheap on trailing earnings, but those earnings are elevated by avian flu-driven egg prices. Margin of safety depends on whether the investor believes earnings can normalize above pre-flu levels, or whether current earnings are peak cycle.
Source-backed data
Every metric below includes a source and last verification date.
| Metric | Value | Source | Last verified |
|---|---|---|---|
| CALM price | $88.34 | Google Finance quote snapshot | July 10, 2026 |
| Market capitalization | $4.19 billion, verified as $88.34 x 47.38 million shares | financial_rigor.py market cap verification | July 12, 2026 |
| Shares outstanding | 47.38 million | Google Finance | July 10, 2026 |
| TTM revenue | Approximately $3.46 billion (four quarters through Feb 2026: $1.10B, $922.60M, $769.50M, $666.95M) | Google Finance income statement quarterly data | July 10, 2026 |
| TTM net income | Approximately $695 million (four quarters through Feb 2026: $342.48M, $199.34M, $102.76M, $50.46M) | Google Finance income statement quarterly data | July 10, 2026 |
| EPS (TTM) | $14.35 | Google Finance | July 10, 2026 |
| P/E ratio (TTM) | 6.16 | Google Finance, verified by financial_rigor.py | July 12, 2026 |
| Dividend | $1.20 quarterly ($4.80 annual), yield 5.45% | Google Finance | July 10, 2026 |
| Technical snapshot | 8-day SMA $84.28, 20-day SMA $80.96, 50-day SMA $78.32, 200-day SMA $82.96, RSI 73.54, MACD 2.35 | Financhill technical analysis snapshot | July 9, 2026 |
| Beta | 0.27 | Google Finance | July 10, 2026 |
This page is an informational research tool only and is not investment advice, financial advice, or a recommendation to buy or sell CALM stock. Forecast scenarios are based on available public data, technical snapshots, and stated assumptions as of the data cutoff date and may be wrong. Always verify current filings, prices, risks, and personal suitability before making financial decisions.
Design trading strategies visually with 10+ indicators. Set entry/exit conditions and risk management, then generate Pine Script code with no coding required.
Filter and discover stocks based on market cap, dividend yield, P/E ratio, sector, and more. Screen thousands of stocks with real-time data.
Smart AI-driven stock selection with fundamental screening, analyst estimates, and key metrics. Filter by P/E, market cap, dividends, and more.
